[1]
2023. REPOSITIONING IVERMECTIN: A BEACON IN COVID-19 PANDEMIC . Journal of Pharmaceutical Negative Results. (Feb. 2023), 378–379. DOI:https://doi.org/10.47750/pnr.2023.14.03.047.